The long and winding road.
出版信息
Nat Rev Drug Discov. 2005 Jun;4(6):443. doi: 10.1038/nrd1770.
DOI:10.1038/nrd1770
PMID:15959946
Abstract
摘要
相似文献
1
The long and winding road.
Nat Rev Drug Discov. 2005 Jun;4(6):443. doi: 10.1038/nrd1770.
2
Market watch: upcoming market catalysts in Q3 2012.
Nat Rev Drug Discov. 2012 Jun 29;11(7):508. doi: 10.1038/nrd3773.
3
Probiotics: from bench to market.
Ann N Y Acad Sci. 2010 Nov;1212 Suppl 1(Suppl 1):E1-14. doi: 10.1111/j.1749-6632.2010.05839.x.
4
Designs that enrich lives.
Arch Pharm (Weinheim). 2007 Oct;340(10):509-10. doi: 10.1002/ardp.200790010.
5
Market watch: Upcoming catalysts in Q3 2014.
Nat Rev Drug Discov. 2014 Jul;13(7):486. doi: 10.1038/nrd4374.
6
Missed opportunities in pharma?
Nat Rev Drug Discov. 2004 Oct;3(10):893. doi: 10.1038/nrd1538.
7
Roche consolidates grip on anti-angiogenesis market.
Nat Biotechnol. 2008 Oct;26(10):1055-6. doi: 10.1038/nbt1008-1055.
8
Pharmaceutical branding: identity, individuality, and illness.
Mol Interv. 2002 Oct;2(6):342-5. doi: 10.1124/mi.2.6.342.
9
Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation.
Nat Rev Drug Discov. 2004 Oct;3(10):822. doi: 10.1038/nrd1541.
10
Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
Clin Ther. 2008 Dec;30(12):2461-73. doi: 10.1016/j.clinthera.2008.12.016.
Zotero 插件